Mesa Laboratories Inc (MLAB)

Operating profit margin

		Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Operating income (ttm)	US$ in thousands	16,336	18,116	12,270	8,702	2,458	-9,329	-5,860	-1,805	-5,539	4,191	-1,723	-1,517	6,004	9,108	11,642	11,911	11,986	8,589	5,186	5,300
Revenue (ttm)	US$ in thousands	240,978	237,747	228,380	223,712	216,187	212,874	213,688	219,272	219,080	222,368	222,777	199,868	184,335	163,420	142,896	138,916	133,937	130,181	127,664	121,340
Operating profit margin		6.78%	7.62%	5.37%	3.89%	1.14%	-4.38%	-2.74%	-0.82%	-2.53%	1.88%	-0.77%	-0.76%	3.26%	5.57%	8.15%	8.57%	8.95%	6.60%	4.06%	4.37%

March 31, 2025 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $16,336K ÷ $240,978K
= 6.78%

Mesa Laboratories Inc's operating profit margin has displayed fluctuations over the periods under consideration. The trend shows a gradual decline from December 31, 2020, to March 31, 2022, with a notable decrease in profitability. The company experienced a negative operating profit margin in the second half of 2022 and the first half of 2023, indicating operational challenges and potential inefficiencies during that period.

However, there was a positive turnaround in the operating profit margin from December 31, 2023, onwards, demonstrating a recovery in profitability. By March 31, 2025, Mesa Laboratories Inc's operating profit margin stood at 6.78%, reflecting improved efficiency and profitability compared to the lows of 2023.

Overall, Mesa Laboratories Inc's operating profit margin trend illustrates a mix of challenges and improvements in managing operating expenses and generating profits over the analyzed periods.